Citadel Advisors’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$680K Buy
48,900
+1,400
+3% +$19.2K ﹤0.01% 8552
2025
Q4
$656K Buy
47,500
+34,900
+277% +$821K ﹤0.01% 8361
2025
Q3
$308K Buy
+12,600
New +$307K ﹤0.01% 10308
2025
Q2
Sell
-26,000
Closed -$702K 13924
2025
Q1
$702K Buy
26,000
+18,100
+229% +$682K ﹤0.01% 7741
2024
Q4
$423K Buy
7,900
+2,600
+49% +$138K ﹤0.01% 8930
2024
Q3
$241K Buy
5,300
+3,500
+194% +$152K ﹤0.01% 9764
2024
Q2
$75.4K Sell
1,800
-11,800
-87% -$554K ﹤0.01% 11278
2024
Q1
$512K Buy
13,600
+8,000
+143% +$174K ﹤0.01% 8344
2023
Q4
$60.1K Buy
5,600
+3,200
+133% +$27.7K ﹤0.01% 11591
2023
Q3
$24.2K Sell
2,400
-14,500
-86% -$167K ﹤0.01% 12469
2023
Q2
$201K Sell
16,900
-35,200
-68% -$470K ﹤0.01% 9884
2023
Q1
$630K Sell
52,100
-7,900
-13% -$131K ﹤0.01% 7824
2022
Q4
$790K Buy
+60,000
New +$878K ﹤0.01% 7283

Other funds holding JANX